How many years have passed since I was able to make a contribution to an AIDS conference! But this year I had the chance to analyze data from a clinical study and present the results on a poster.

Ronel, J., Bührlen, B., Fischer, F., Boesecke, C., Kümmerle, T., Schneider, J., … The DUALIS Study Group. (2019, November 6). A switch to dolutegravir in combination with boosted darunavir is safe and effective in suppressed patients with HIV - a predefined psychosocial subanalysis of the DUALIS study. Poster presented at the 17th European AIDS Conference, Basel, Switzerland. Download: http://resourcelibrary.eacs.cyim.com/mediatheque/media.aspx?mediaId=78238&channel=28172

And I learned a lot about R during this undertaking! A whole world of statistics and more.

Save
Cookies user preferences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Functional
Tools used to give you more features when navigating on the website, this can include social sharing.
Cookie-consent
Accept
Decline
Essential
These cookies are needed to make the website work correctly. You can not disable them.
Marketing
Set of techniques which have for object the commercial strategy and in particular the market study.
Quantcast
Accept
Decline